BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10571528)

  • 1. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation.
    Fukumoto S; Koyama H; Hosoi M; Yamakawa K; Tanaka S; Morii H; Nishizawa Y
    Circ Res; 1999 Nov; 85(11):985-91. PubMed ID: 10571528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation.
    Tanner FC; Meier P; Greutert H; Champion C; Nabel EG; Lüscher TF
    Circulation; 2000 Apr; 101(16):1982-9. PubMed ID: 10779466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2.
    Vadiveloo PK; Filonzi EL; Stanton HR; Hamilton JA
    Atherosclerosis; 1997 Aug; 133(1):61-9. PubMed ID: 9258408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.
    Takahashi A; Taniguchi T; Ishikawa Y; Yokoyama M
    Circ Res; 1999 Mar; 84(5):543-50. PubMed ID: 10082476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells.
    Stuart WD; Maeda S; Khera P; Fagin JA; Clemens TL
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E60-7. PubMed ID: 10893323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.
    L'Allemain G; Lavoie JN; Rivard N; Baldin V; Pouyssegur J
    Oncogene; 1997 Apr; 14(16):1981-90. PubMed ID: 9150365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
    Hupfeld CJ; Weiss RH
    Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
    Morisaki H; Ando A; Nagata Y; Pereira-Smith O; Smith JR; Ikeda K; Nakanishi M
    Exp Cell Res; 1999 Dec; 253(2):503-10. PubMed ID: 10585273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying maintenance of smooth muscle cell quiescence in rat aorta: role of the cyclin dependent kinases and their inhibitors.
    Izzard TD; Taylor C; Birkett SD; Jackson CL; Newby AC
    Cardiovasc Res; 2002 Jan; 53(1):242-52. PubMed ID: 11744034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells.
    Nathe TJ; Deou J; Walsh B; Bourns B; Clowes AW; Daum G
    Arterioscler Thromb Vasc Biol; 2002 Aug; 22(8):1293-8. PubMed ID: 12171790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP inhibits linoleic acid-induced growth by antagonizing p27(kip1) depletion, but not interfering with the extracellular signal-regulated kinase or AP-1 activities.
    Hu ZY; Madamanchi NR; Rao GN
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):139-46. PubMed ID: 9784625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation.
    Kavurma MM; Khachigian LM
    J Biol Chem; 2003 Aug; 278(35):32537-43. PubMed ID: 12796485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.